Burst Suppression in Refractory Status Epilepticus
medium
syringe Anesthesia
A 34-year-old woman with autoimmune encephalitis is admitted with refractory status epilepticus (RSE) unresponsive to lorazepam and levetiracetam. She is intubated and sedated. Continuous EEG monitoring shows the pattern marked **A** in the diagram — high-voltage bursts alternating with periods of generalized voltage suppression. Which of the following best describes the clinical significance and management goal of the EEG pattern marked **A**?
A. Represents alpha coma from severe anoxic brain injury; indicates irreversible neurological damage and poor prognosis regardless of anaesthetic therapy
B. Indicates early seizure control with benzodiazepines alone; requires no further escalation of therapy and can be managed with standard ICU monitoring
C. Reflects profound cortical suppression induced by high-dose IV anaesthetic infusion; titrated to maintain burst suppression with interburst intervals of 5–10 seconds for 24–48 hours before weaning
D. Shows diffuse metabolic encephalopathy from sepsis; requires antibiotics and supportive care rather than continuous IV anaesthetic infusion
Explanation
Why option 1 is correct
Burst suppression (BS) — the pattern marked A — is defined as high-voltage bursts (mixed-frequency polyphasic spikes and sharp waves >100 µV lasting 1–3 seconds) separated by generalized voltage suppression <10 µV (interburst interval, IBI) lasting >1 second. In refractory status epilepticus, BS is induced deliberately by escalation to continuous IV anaesthetic infusion (pentobarbital, midazolam, or propofol) and reflects profound cortical suppression. The Neurocritical Care Society guideline specifies that cEEG titration targets burst suppression with IBI of 5–10 seconds, maintained for 24–48 hours before slow weaning. This is the gold standard for super-refractory status epilepticus (SRSE) — RSE persisting >24 hours after anaesthetic therapy initiation.
Why each distractor is wrong
Option 2: Burst suppression is NOT early seizure control with benzodiazepines alone. By definition, RSE has already failed first-line benzodiazepines and second-line agents (levetiracetam, fosphenytoin, valproate, lacosamide). BS requires escalation to continuous IV anaesthetic infusion and represents a much deeper level of suppression than benzodiazepine monotherapy can achieve.
Option 3: While burst suppression can occur in severe anoxic brain injury (anoxic encephalopathy after cardiac arrest), the clinical context here is autoimmune encephalitis with RSE. Moreover, BS in the setting of RSE managed with anaesthetic therapy is NOT a marker of irreversible damage; it is a therapeutic target. The prognosis depends on treatment of the underlying cause and response to escalated therapy, not on BS pattern alone.
Option 4: Burst suppression is not a sign of sepsis-induced metabolic encephalopathy. The pattern marked A is specifically induced by high-dose anaesthetic agents (pentobarbital, midazolam, propofol) in the context of RSE/SRSE. Sepsis would present with other EEG patterns (e.g., generalized periodic discharges or diffuse slowing) and requires antibiotics, not anaesthetic coma titration.
High-YieldNEET PG
Burst suppression in RSE is a THERAPEUTIC TARGET (not a sign of irreversible damage) — maintain IBI 5–10 seconds for 24–48 hours with continuous IV anaesthetic infusion; continuous EEG is mandatory because clinical seizures are masked by paralytics and sedation.
Neurocritical Care Society Status Epilepticus Guideline 2012; Brophy et al
Practice similar questions
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.
